BioSpace News Archive

Policy

U.S. FDA Grants Full Approval of REZUROCK(TM) (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD)

Kadmon Holdings, Inc. announced that the U.S. Food and Drug Administration has approved REZUROCK™ 200 mg once daily for the treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease after failure of at least two prior lines of systemic therapy.

July 16, 2021
·
10 min read
Business

Vertex to Announce Second-Quarter 2021 Financial Results on July 29

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second-quarter 2021 financial results on Thursday, July 29, 2021 after the financial markets close.

July 16, 2021
·
2 min read
Biotech Beach

CytRx Corporation Announces Closing of $10 Million Offering to Healthcare-Focused Institutional Investor

CytRx Corporation today announced the closing of its previously announced sale of its securities pursuant to a securities purchase agreement (the “Purchase Agreement”) to a single healthcare-focused institutional investor (the “Investor”) for aggregate gross proceeds of approximately $10 million.

July 16, 2021
·
5 min read
Deals

Thinking about buying stock in Ion Geophysical, Moneygram International, Akebia Therapeutics, iBio, or Exela Technologies?

InvestorsObserver issues critical PriceWatch Alerts for IO, MGI, AKBA, IBIO, and XELA.

July 16, 2021
·
1 min read
Business

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 10, 2021

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2021 results on Tuesday, August 10, 2021.

July 16, 2021
·
1 min read